MolecuLight Secures Financing from BDC Canada and iGan Partners to Support its Commercial Expansion
New Financing to Meet Significant Growth in Global Demand for MolecuLight's i:X® and DXâ'¢ Point-of-Care Imaging Devices for the Wound Care Industry
TORONTO, Aug. 11, 2022 /PRNewswire/ - MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DXâ'¢Â devices.
Article
Lupita Nyo...
Argyle Lak...
Salzgitter...
MolecuLigh...
Kentucky R...
New Englan...
Lorem ipsum dolor sit amet.
Praesent placerat ipsum nec mi maximus, vel cursus mauris cursus. Vivamus cursus ante eget orci egestas malesuada.
Article
TROY 1-Day...
Spain evac...
Lupita Nyo...
Argyle Lak...
Salzgitter...
MolecuLigh...